Cargando…

Efficacy of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study

BACKGROUND: Benralizumab, an anti-interleukin-5 (IL-5) receptor α monoclonal antibody, significantly reduces the number of annual exacerbations and oral corticosteroid (OCS) maintenance doses for patients with severe eosinophilic asthma (SEA). However, few studies on the efficacy of this biologic in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Numata, Takanori, Miyagawa, Hanae, Nishioka, Saiko, Okuda, Keitaro, Utsumi, Hirofumi, Hashimoto, Mitsuo, Minagawa, Shunsuke, Ishikawa, Takeo, Hara, Hiromichi, Araya, Jun, Kuwano, Kazuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398222/ https://www.ncbi.nlm.nih.gov/pubmed/32746787 http://dx.doi.org/10.1186/s12890-020-01248-x

Ejemplares similares

Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study
por: Numata, Takanori, et al.
Publicado: (2022)

Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study
por: Numata, Takanori, et al.
Publicado: (2021)

Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study
por: Numata, Takanori, et al.
Publicado: (2022)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
por: Numata, Takanori, et al.
Publicado: (2019)

Possible relationship between esophageal dilatation and severity of M. abscessus pulmonary disease
por: Hara, Hiromichi, et al.
Publicado: (2021)

Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib
por: Takekoshi, Daisuke, et al.
Publicado: (2020)

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis
por: Miyagawa, Hanae, et al.
Publicado: (2021)

Prostaglandin E-Major Urinary Metabolite (PGE-MUM) as a Tumor Marker for Lung Adenocarcinoma
por: Kawamoto, Hironori, et al.
Publicado: (2019)

Risk factors of postoperative pulmonary complications in patients with asthma and COPD
por: Numata, Takanori, et al.
Publicado: (2018)

Real-life effectiveness of dupilumab in patients with mild to moderate bronchial asthma comorbid with CRSwNP
por: Minagawa, Shunsuke, et al.
Publicado: (2022)

Minoxidil-induced lung disease, masquerading as hypersensitivity pneumonitis
por: Takekosh, Daisuke, et al.
Publicado: (2023)

Mild Lung Tuberculosis in a Patient Suffering from Status Epilepticus Caused by the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)
por: Hashimoto, Mitsuo, et al.
Publicado: (2017)

Interstitial Pneumonia in Psoriasis
por: Kawamoto, Hironori, et al.
Publicado: (2018)

Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy
por: Kurita, Yusuke, et al.
Publicado: (2017)

Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease
por: Fujii, Satoko, et al.
Publicado: (2012)

Successful treatment of eosinophilic cystitis with benralizumab
por: Cooke, W Donald, et al.
Publicado: (2020)

Eosinophilic bronchiolitis successfully treated with benralizumab
por: Sugino, Keishi, et al.
Publicado: (2021)

The usefulness of change in CT score for evaluating the activity of Mycobacterium abscessus (Mab) pulmonary disease (Mab-PD)
por: Shinfuku, Kyota, et al.
Publicado: (2023)

Metformin attenuates lung fibrosis development via NOX4 suppression
por: Sato, Nahoko, et al.
Publicado: (2016)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia
por: Isomoto, Kohsuke, et al.
Publicado: (2020)

A case of pulmonary lymphangioleiomyomatosis complicated with uterine and retroperitoneal tumors
por: Numata, Takanori, et al.
Publicado: (2015)

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
por: Jackson, David J., et al.
Publicado: (2020)

Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia
por: Ito, Akihiko, et al.
Publicado: (2022)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
por: Noorduyn, Stephen G., et al.
Publicado: (2021)

Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis
por: Koga, Yasuhiko, et al.
Publicado: (2022)

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
por: Gómez-Bastero Fernández, Ana, et al.
Publicado: (2022)

Treatment of Widespread Eosinophilic Cellulitis (Wells’ Syndrome) with Benralizumab
por: BLOMBERG, Maria, et al.
Publicado: (2020)

Eosinophilic annular erythema showing eosinophil cytolytic ETosis successfully treated with benralizumab
por: Masaki, Katsunori, et al.
Publicado: (2021)

Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection
por: Takano, Tomotsugu, et al.
Publicado: (2021)

Rapid effect of benralizumab in fulminant eosinophilic myocarditis in the setting of uncontrolled eosinophilic asthma
por: Goyack, Laura, et al.
Publicado: (2023)

Detection of pathogens by real-time PCR in adult patients with acute exacerbation of bronchial asthma
por: Yoshii, Yutaka, et al.
Publicado: (2017)

Mitochondrial Quality Control in COPD and IPF
por: Hara, Hiromichi, et al.
Publicado: (2018)

Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
por: Martínez-Rivera, Carlos, et al.
Publicado: (2021)

Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With Benralizumab
por: Sasaki, Hisashi, et al.
Publicado: (2022)

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
por: Nanzer, Alexandra M., et al.
Publicado: (2020)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
por: Woodbury, Michael J., et al.
Publicado: (2023)

Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases
por: Sridhar, Sriram, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m63a0dkpeuai5a31dnj3hqasb6